LATEST NEWS

The Future of Retinal Disease Treatment
New gene therapies, deeper insights into stem cells, and advances in imaging and artificial intelligence are making researchers, physicians, and some patients optimistic about retinal disease treatment. 
FDA Warns 15 Companies Selling CBD Products
Safety concerns include liver injury and interactions with other drugs
Texas Safe Drug Disposal Law Goes Into Effect January
DisposeRx helps with compliance
Lung Association to Smokers: 'Quit, Don't Switch' to E-Cigarettes
No tobacco product is safe, says the lung heath group
Researchers Find Clue to How M. Tuberculosis Replicates
Discovery seen as possibly leading to new anti-TB drugs
Hair Products May Increase Breast Cancer Risk
Study points to permanent hair dye and straighteners
Home Urine Test Could Revolutionize Prostate Cancer Diagnosis
No more digital rectal exams?
A Key to Resistance?
How malaria parasites evade first-line drugs
Clever Drugs for Slimy Bugs
A new way to fight staph infections
Researchers Develop a Risk Score for Opioid Misuse
Score could help prevent misuse among cancer patients
Quick Eye Test May Flag Unrecognized Brain Injury
'All head impacts are not the same'

P&T November 2019
Table of Contents

Features

Are We Any Safer After 20 Years?

Two decades after the landmark To Err Is Human report was published, patient safety has improved but medication errors remain a significant problem.

Efficacy of Modafinil, Methylphenidate, Amantadine, and Zolpidem in Consciousness Recovery in Intensive Care Unit Patients with Traumatic Brain Injury

Amantadine had the highest response rate as an awakening agent among TBI patients in the ICU in this retrospective chart review study.

Impact of Physician Engagement During Formulary Decision-Making on Prescribing Practices and Formulary Adherence at an Academic Medical Center

Shouldn’t engaging physicians in formulary decisions improve formulary adherence? This study at an academic medical center found otherwise.

Health Care & Law
Digital Health: A New-Age Spectrum of Therapeutics

Digital health products are coming on strong, and P&T committees and health care professionals will have to manage their use.

Departments

Prescription: Washington
P&T Committees May Want to Alter Some Formulary Policies Because of New Medicare Part D Standards

CMS proposes new standard electronic prior authorization.

Medication Errors
Reporting and Second-Order Problem Solving Can Turn Short-Term Fixes Into Long-Term Remedies

Workarounds may get the job done but may let long-term problems fester.

Industry announcements

More industry announcements